Cargando…
Intussusception after Rotavirus Vaccine Introduction in India
BACKGROUND: Rotavac®, an Indian-made, 3-dose, oral rotavirus vaccine, was introduced in the universal immunization program in India in 2016. Pre-licensure safety data for the vaccine were limited to a single trial of 6800 Indian infants; here we report results of a post-marketing surveillance study...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492078/ https://www.ncbi.nlm.nih.gov/pubmed/33176083 http://dx.doi.org/10.1056/NEJMoa2002276 |